- Home
- RLMD vs JLS Comparison
RLMD vs JLS Comparison
Compare RLMD & JLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLMD
- JLS
- Stock Information
- Founded
- RLMD 2004
- JLS 2009
- Country
- RLMD United States
- JLS United States
- Employees
- RLMD N/A
- JLS N/A
- Industry
- RLMD Biotechnology: Pharmaceutical Preparations
- JLS Investment Managers
- Sector
- RLMD Health Care
- JLS Finance
- Exchange
- RLMD Nasdaq
- JLS Nasdaq
- Market Cap
- RLMD 110.6M
- JLS 99.0M
- IPO Year
- RLMD N/A
- JLS N/A
- Fundamental
- Price
- RLMD $3.16
- JLS $18.08
- Analyst Decision
- RLMD Hold
- JLS
- Analyst Count
- RLMD 2
- JLS 0
- Target Price
- RLMD $7.50
- JLS N/A
- AVG Volume (30 Days)
- RLMD 110.4K
- JLS 26.6K
- Earning Date
- RLMD 11-07-2024
- JLS 01-01-0001
- Dividend Yield
- RLMD N/A
- JLS 9.33%
- EPS Growth
- RLMD N/A
- JLS N/A
- EPS
- RLMD N/A
- JLS N/A
- Revenue
- RLMD N/A
- JLS N/A
- Revenue This Year
- RLMD N/A
- JLS N/A
- Revenue Next Year
- RLMD N/A
- JLS N/A
- P/E Ratio
- RLMD N/A
- JLS N/A
- Revenue Growth
- RLMD N/A
- JLS N/A
- 52 Week Low
- RLMD $1.88
- JLS $15.48
- 52 Week High
- RLMD $7.22
- JLS $17.97
- Technical
- Relative Strength Index (RSI)
- RLMD 39.24
- JLS 42.10
- Support Level
- RLMD $3.06
- JLS $18.05
- Resistance Level
- RLMD $3.43
- JLS $18.56
- Average True Range (ATR)
- RLMD 0.20
- JLS 0.22
- MACD
- RLMD -0.04
- JLS -0.01
- Stochastic Oscillator
- RLMD 16.30
- JLS 21.20
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
About JLS Nuveen Mortgage and Income Fund
Nuveen Mortgage And Income Fund is a diversified, closed-end management investment company. The Fund invests at least fifty percent of its Managed Assets in MBS, including residential MBS and commercial MBS, and up to fifty percent in non-mortgage related ABS. Its investment objective to generate high current income through opportunistic investments in securitized credit.